UiPath presents a high-quality mid‑cap AI/automation play. It has the fundamentals—a fortress balance sheet, growing ARR, strategic positioning in RPA+AI—and operational leverage through partnerships and ecosystem credibility. However:

• It's still unprofitable, requiring further margins improvement to bridge the valuation gap.

• The technical catalyst (breakout above ~$13.35) hasn’t fully materialized, risk management is key.

• Analyst consensus is lukewarm, expecting modest upside.

Recommendation: For investors bullish on long-term AI-driven automation, a selective entry around $13–$13.50, with a tight stop-loss (e.g., ~$12), could be rewarded if UiPath delivers sustained growth and margin improvement. Conservative investors may prefer to wait for financials to shift profitable and for technical confirmation.

Why UiPath?

Why Synopsys is a Hidden Gem?

1. Growing in a High-Barriers Industry

• Synopsys is a leader in Electronic Design Automation (EDA), essential software for chip design. Their tools are integral to developing advanced AI and high-performance chips

• They're capitalizing on the AI chip boom—analysts attribute upside to strong demand, particularly outside China

2. Stellar Financial Profile

Welcome to the group! I will be sharing investment ideas with fundamental explanations. You can connect with other members, get updates and share your thoughts.